Unknown

Dataset Information

0

High glucose induces Smad activation via the transcriptional coregulator p300 and contributes to cardiac fibrosis and hypertrophy.


ABSTRACT:

Background

Despite advances in the treatment of heart failure, mortality remains high, particularly in individuals with diabetes. Activated transforming growth factor beta (TGF-?) contributes to the pathogenesis of the fibrotic interstitium observed in diabetic cardiomyopathy. We hypothesized that high glucose enhances the activity of the transcriptional co-activator p300, leading to the activation of TGF-? via acetylation of Smad2; and that by inhibiting p300, TGF-? activity will be reduced and heart failure prevented in a clinically relevant animal model of diabetic cardiomyopathy.

Methods

p300 activity was assessed in H9c2 cardiomyoblasts under normal glucose (5.6 mmol/L-NG) and high glucose (25 mmol/L-HG) conditions. 3H-proline incorporation in cardiac fibroblasts was also assessed as a marker of collagen synthesis. The role of p300 activity in modifying TGF-? activity was investigated with a known p300 inhibitor, curcumin or p300 siRNA in vitro, and the functional effects of p300 inhibition were assessed using curcumin in a hemodynamically validated model of diabetic cardiomyopathy - the diabetic TG m(Ren-2)27 rat.

Results

In vitro, H9c2 cells exposed to HG demonstrated increased p300 activity, Smad2 acetylation and increased TGF-? activity as assessed by Smad7 induction (all p ConclusionsThese findings suggest that high glucose increases the activity of the transcriptional co-regulator p300, which increases TGF-? activity via Smad2 acetylation. Modulation of p300 may be a novel strategy to treat diabetes induced heart failure.

SUBMITTER: Bugyei-Twum A 

PROVIDER: S-EPMC4108062 | biostudies-literature | 2014 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

High glucose induces Smad activation via the transcriptional coregulator p300 and contributes to cardiac fibrosis and hypertrophy.

Bugyei-Twum Antoinette A   Advani Andrew A   Advani Suzanne L SL   Zhang Yuan Y   Thai Kerri K   Kelly Darren J DJ   Connelly Kim A KA  

Cardiovascular diabetology 20140505


<h4>Background</h4>Despite advances in the treatment of heart failure, mortality remains high, particularly in individuals with diabetes. Activated transforming growth factor beta (TGF-β) contributes to the pathogenesis of the fibrotic interstitium observed in diabetic cardiomyopathy. We hypothesized that high glucose enhances the activity of the transcriptional co-activator p300, leading to the activation of TGF-β via acetylation of Smad2; and that by inhibiting p300, TGF-β activity will be red  ...[more]

Similar Datasets

| S-EPMC5621875 | biostudies-literature
| S-EPMC8321812 | biostudies-literature
| S-EPMC2726266 | biostudies-literature
| S-EPMC5787338 | biostudies-literature
| S-EPMC8751916 | biostudies-literature
2021-07-23 | GSE174193 | GEO
| S-EPMC6433695 | biostudies-literature
| S-EPMC4568756 | biostudies-literature
| S-EPMC9393479 | biostudies-literature
| S-EPMC8755933 | biostudies-literature